Maintaining low residual hydrogen peroxide at critical filling locations. An operating example shows a 36% longer cycle than the original validation, with the entire difference in the residual measurement phase.
Catalyst capacity affects isolator aeration after vaporized hydrogen peroxide (VHP) bio-decontamination, and the residual H2O2 at critical filling locations. This paper presents an operating example that documents a 36% increase in time from aeration-start to completed residual measurement compared with the original validation. This does not alone establish catalyst deterioration as the cause. Automatic extension of the cycle cannot ensure acceptable concentrations at unmeasured locations without a validated relationship supporting that assurance. Planned reactivation of the catalyst helps maintain the catalyst capacity on which this relationship depends.
Three validation runs in January 2025 established a consistent baseline on an isolator filling line. A later operating cycle in August 2026, after smoke studies on the same line, required 19 minutes 30 seconds longer.
| Process stage | Original validationJanuary 2025 | Operating cycleAugust 2026 |
|---|---|---|
| Aeration phases 1 and 2 | 50:01–50:02 | 49:57 |
| Transition to residual measurement | 3:01 | 3:01 |
| Residual measurement phase | 1:00 | 20:35 |
| Total elapsed time | 54:02–54:03 | 73:33 |
Times in minutes : seconds, from aeration-start to completion of residual measurement.
Why catalyst capacity matters. How catalyst capacity links to residual H2O2 where product is exposed, and how this relates to EU GMP Annex 1, section 4.22.
How smoke residues can reduce catalyst capacity. Why glycol-based airflow visualization smoke can foul catalyst surfaces, and why water-based fog avoids the risk.
Why automatic extension is not sufficient evidence. Passing the machine sensor threshold does not, by itself, show that residual concentrations at critical filling locations match those established during validation.
Reactivation during planned shutdowns. A preventive alternative to replacing catalysts only after a performance problem appears.
The full operating evidence. Trend data from the original validation and the later cycle, with an assessment of what the change means for the validated state.
Five pages with trend figures, Table 1 and five cited sources, including EU GMP Annex 1, PIC/S PI 014-3 and peer-reviewed research. Fill in the short form below and the PDF is yours.
Five pages, trend figures and five cited sources. Fill in the form and your download opens straight away.
The world's first reactivation service for pharmaceutical-grade H₂O₂ isolator catalysts. Validated, documented, returned in days.
